Last edition
News about
Amgen Announces Positive Phase 3 Results for TEPEZZA
Amgen reports positive Phase 3 topline results for subcutaneous TEPEZZA in thyroid eye disease, with key endpoints met and 77 percent of patients achieving significant proptosis reduction.
Neurocrine to Acquire Soleno Therapeutics
Neurocrine to acquire Soleno Therapeutics, adding US FDA-approved VYKAT XR for Prader-Willi Syndrome and strengthening its rare disease and endocrinology portfolio.
UPSIDA, JNPA Partner to Position Lalitpur Pharma Park as Export Hub
Uttar Pradesh State Industrial Development Authority (UPSIDA) has signed an agreement with Jawaharlal Nehru Port Authority (JNPA) to develop the Lalitpur Pharma Park into a global pharmaceutical export hub.
Medicus Pharma Submits Phase 2 Protocol to US FDA for Teverelix in Acute Urinary Retention
Medicus Pharma submits Phase 2 protocol to US FDA for Teverelix in acute urinary retention, targeting a USD 2 billion market with a mechanism-driven, capital-efficient development strategy.
Strategic Alliance Targets Faster, High-Yield Biologics Manufacturing
OneCyte and Kemp Proteins have announced a strategic partnership to deliver advanced cell line development solutions for biopharmaceutical companies globally.
University of Manchester Develops SAFER-Dem Tool to Improve Dementia Patient Discharges
Researchers develop SAFER-Dem, a new care tool designed to make hospital discharge safer and more patient-centred for people living with dementia.
Cipla USA Secures USFDA Approval for Generic Nintedanib to Treat Pulmonary Fibrosis
Cipla USA receives USFDA approval for generic Nintedanib capsules, expanding access to treatment for patients with idiopathic pulmonary fibrosis in the United States.
Biocytogen and Sihuan Pharmaceutical Partner to Advance Next-Gen Antibody Therapies
The strategic collaboration between Bioctogen and Sihuan Pharmaceutical combines antibody discovery platforms and manufacturing expertise to accelerate development of innovative treatments, including weight loss therapies.
Caris Launches World's First ChromoSeq for Myeloid Malignancies
Caris Life Sciences launches ChromoSeq, the world’s first whole genome and transcriptome assay for myeloid malignancies, offering deeper insights and faster diagnosis.
Pharma Logistics Demand Surges as War Disrupts Global Supply Chains
Pharmaceutical logistics is witnessing a sharp surge in demand as global supply chains face mounting disruptions from geopolitical conflicts, pandemics, and trade uncertainties.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy